{"success":true,"data":{"pressRelease":{"id":"133233","rtpr_id":"nBw9LT1cha","ticker":"NPCE","exchange":"NASDAQ","all_tickers":["NPCE"],"title":"NeuroPace to Participate in 2026 Cantor Global Healthcare Conference","author":"Business Wire","published_at":"2026-09-01T21:02:00.138Z","article_body":"NeuroPace to Participate in 2026 Cantor Global Healthcare Conference\n\nNeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on\ntransforming the lives of people living with epilepsy, today announced that\nits management team will participate in the upcoming 2026 Cantor Global\nHealthcare Conference.\n\nNeuroPace management will participate in a fireside chat discussion on\nWednesday, September 9 at 10:55am EDT, and host one-on-one meetings with\ninvestors during the conference. The fireside chat will be accessible via a\nlive webcast here\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsqps.onstreamsecure.com%2Forigin%2Fenliven%2Fplayers%2FEnlivenPlayer.html%3FcustomerId%3D22%26eventId%3D10176524%26checkCompany%3D1%26checkEmail%3D1%26checkName%3D1&esheet=54597656&newsitemid=20260901798004&lan=en-US&anchor=here&index=1&md5=7868ce18ac028f382f5e0bb9b01434e3)\nand a replay will be available on the Events section of NeuroPace’s Investor\nwebsite at https://investors.neuropace.com/news-and-events/events\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestors.neuropace.com%2Fnews-and-events%2Fevents&esheet=54597656&newsitemid=20260901798004&lan=en-US&anchor=https%3A%2F%2Finvestors.neuropace.com%2Fnews-and-events%2Fevents&index=2&md5=ff4281a62f74ff4f6f0947ae3e65057e)\n.\n\nAbout NeuroPace, Inc.\n\nBased in Mountain View, Calif., NeuroPace is a medical device company focused\non transforming the lives of people living with epilepsy by reducing or\neliminating the occurrence of debilitating seizures. Its novel and\ndifferentiated RNS System is the first and only commercially available,\nbrain-responsive platform that delivers personalized, real-time treatment at\nthe seizure source. This platform can drive a better standard of care for\npatients living with drug-resistant epilepsy and has the potential to offer a\nmore personalized solution and improved outcomes to the large population of\npatients suffering from other brain disorders.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260901798004/en/\n(https://www.businesswire.com/news/home/20260901798004/en/)\n\nInvestor Contact: \n\nScott Schaper\n\nHead of Investor Relations\n\nsschaper@neuropace.com \n(mailto:sschaper@neuropace.com) \ninvestors@neuropace.com (mailto:investors@neuropace.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw9LT1cha","title":"NeuroPace to Participate in 2026 Cantor Global Healthcare Conference","author":"Business Wire","ticker":"NPCE","created":"2026-09-01T21:02:00.138Z","tickers":["NPCE"],"exchange":"NASDAQ","article_body":"NeuroPace to Participate in 2026 Cantor Global Healthcare Conference\n\nNeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on\ntransforming the lives of people living with epilepsy, today announced that\nits management team will participate in the upcoming 2026 Cantor Global\nHealthcare Conference.\n\nNeuroPace management will participate in a fireside chat discussion on\nWednesday, September 9 at 10:55am EDT, and host one-on-one meetings with\ninvestors during the conference. The fireside chat will be accessible via a\nlive webcast here\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsqps.onstreamsecure.com%2Forigin%2Fenliven%2Fplayers%2FEnlivenPlayer.html%3FcustomerId%3D22%26eventId%3D10176524%26checkCompany%3D1%26checkEmail%3D1%26checkName%3D1&esheet=54597656&newsitemid=20260901798004&lan=en-US&anchor=here&index=1&md5=7868ce18ac028f382f5e0bb9b01434e3)\nand a replay will be available on the Events section of NeuroPace’s Investor\nwebsite at https://investors.neuropace.com/news-and-events/events\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestors.neuropace.com%2Fnews-and-events%2Fevents&esheet=54597656&newsitemid=20260901798004&lan=en-US&anchor=https%3A%2F%2Finvestors.neuropace.com%2Fnews-and-events%2Fevents&index=2&md5=ff4281a62f74ff4f6f0947ae3e65057e)\n.\n\nAbout NeuroPace, Inc.\n\nBased in Mountain View, Calif., NeuroPace is a medical device company focused\non transforming the lives of people living with epilepsy by reducing or\neliminating the occurrence of debilitating seizures. Its novel and\ndifferentiated RNS System is the first and only commercially available,\nbrain-responsive platform that delivers personalized, real-time treatment at\nthe seizure source. This platform can drive a better standard of care for\npatients living with drug-resistant epilepsy and has the potential to offer a\nmore personalized solution and improved outcomes to the large population of\npatients suffering from other brain disorders.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260901798004/en/\n(https://www.businesswire.com/news/home/20260901798004/en/)\n\nInvestor Contact: \n\nScott Schaper\n\nHead of Investor Relations\n\nsschaper@neuropace.com \n(mailto:sschaper@neuropace.com) \ninvestors@neuropace.com (mailto:investors@neuropace.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-01T21:02:00.17822781Z","server_sent_at_ms":1788296520178},"received_at":"2026-09-01T21:02:00.263Z","source_url":"https://www.businesswire.com/news/home/20260901798004/en/"},"analysis":{"id":"122124","press_release_id":"133233","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"NeuroPace announced that management will participate in the upcoming 2026 Cantor Global Healthcare Conference.\n\nThe company is scheduled for a fireside chat on September 9 at 10:55 a.m. EDT and will host one-on-one meetings with investors.\n\nThe fireside chat will be accessible via live webcast, with a replay available on the NeuroPace investor website.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference participation announcement."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Scott Schaper","role":"Head of Investor Relations"}],"products":["RNS System"],"companies":[{"name":"NeuroPace, Inc.","ticker":"NPCE"},{"name":"Cantor","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine investor relations announcement regarding conference participation; no material financial or operational updates disclosed."},"tickerRelevance":{"others":[],"primary":"NPCE"},"globalImportance":5,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine_IR","sectorWeight":"standard"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"NeuroPace announced that management will participate in the upcoming 2026 Cantor Global Healthcare Conference.\n\nThe company is scheduled for a fireside chat on September 9 at 10:55 a.m. EDT and will host one-on-one meetings with investors.\n\nThe fireside chat will be accessible via live webcast, with a replay available on the NeuroPace investor website.","key_figures":null,"named_entities":{"people":[{"name":"Scott Schaper","role":"Head of Investor Relations"}],"products":["RNS System"],"companies":[{"name":"NeuroPace, Inc.","ticker":"NPCE"},{"name":"Cantor","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-01T21:34:17.294Z","global_importance":5,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine_IR","sectorWeight":"standard"}},"durationMs":110419,"modelName":"glm-4.7"}}